WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$152M |
| 3 |
Brown & Brown
BRO
|
$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
$113M |
| 5 |
Akero Therapeutics
AKRO
|
$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
$144M |
| 2 |
MetLife
MET
|
$97.2M |
| 3 |
Travelers Companies
TRV
|
$91.9M |
| 4 |
Electronic Arts
EA
|
$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Salesforce
CRM
$239B
| $12.5M | 0.07% |
45,864
-22,943
| -33% | -$6.26M |
|
377
Axalta
AXTA
$6.89B
| $12.5M | 0.07% |
+420,945
| New | +$12.5M |
|
378
Accenture
ACN
$159B
| $12.4M | 0.07% |
41,582
-146,717
| -78% | -$43.9M |
|
379
Lamb Weston
LW
$8.08B
| $12.4M | 0.07% |
239,058
+71,181
| +42% | +$3.69M |
|
380
PENN Entertainment
PENN
$2.99B
| $12.2M | 0.06% |
+682,547
| New | +$12.2M |
|
381
Loar Holdings
LOAR
$7.16B
| $12.2M | 0.06% |
141,210
+105,062
| +291% | +$9.05M |
|
382
Teva Pharmaceuticals
TEVA
$21.7B
| $12.1M | 0.06% |
724,910
-319,700
| -31% | -$5.36M |
|
383
89bio
ETNB
$1.32B
| $12M | 0.06% |
1,222,661
+521,907
| +74% | +$5.13M |
|
384
LKQ Corp
LKQ
$8.33B
| $12M | 0.06% |
324,317
-13,447
| -4% | -$498K |
|
385
Biogen
BIIB
$20.6B
| $12M | 0.06% |
95,560
-29,602
| -24% | -$3.72M |
|
386
Ulta Beauty
ULTA
$23.1B
| $12M | 0.06% |
+25,629
| New | +$12M |
|
387
Teledyne Technologies
TDY
$25.7B
| $11.9M | 0.06% |
+23,253
| New | +$11.9M |
|
388
Blackstone
BX
$133B
| $11.8M | 0.06% |
78,925
+17,088
| +28% | +$2.56M |
|
389
Arrowhead Research
ARWR
$4.02B
| $11.8M | 0.06% |
746,156
+183,981
| +33% | +$2.91M |
|
|
CRCL
390
Circle Internet Group, Inc.
CRCL
$26.5B
| $11.8M | 0.06% |
+65,000
| New | +$11.8M |
|
391
Gartner
IT
$18.6B
| $11.6M | 0.06% |
+28,595
| New | +$11.6M |
|
|
MAZE
392
Maze Therapeutics, Inc. Common Stock
MAZE
$696M
| $11.5M | 0.06% |
940,700
+11,598
| +1% | +$142K |
|
393
Erie Indemnity
ERIE
$17.5B
| $11.5M | 0.06% |
+33,202
| New | +$11.5M |
|
394
Informatica
INFA
$7.55B
| $11.5M | 0.06% |
472,302
+452,769
| +2,318% | +$11M |
|
395
Pinterest
PINS
$25.8B
| $11.5M | 0.06% |
+319,561
| New | +$11.5M |
|
396
Enovis
ENOV
$1.84B
| $11.4M | 0.06% |
364,895
| – | – |
|
397
Intellia Therapeutics
NTLA
$1.29B
| $11.4M | 0.06% |
1,219,068
+1,194,962
| +4,957% | +$11.2M |
|
|
MTSR
398
Metsera, Inc. Common Stock
MTSR
$3.77B
| $11.4M | 0.06% |
400,785
+100,568
| +33% | +$2.86M |
|
399
Viridian Therapeutics
VRDN
$1.53B
| $11.4M | 0.06% |
815,485
+1,838
| +0.2% | +$25.7K |
|
400
Intercontinental Exchange
ICE
$99.8B
| $11.4M | 0.06% |
62,048
+13,505
| +28% | +$2.48M |
|